| Purity: | 99 |
|---|---|
| Model Number: | 36322-90-4 |
| Brand Name: | NJBN STEROID |
| Grade Standard: | Medicine Grade |
| Type: | Vitamins, Amino Acids and Coenzymes |
| Place of Origin: | China (Mainland) |
| EINECS No.: | 252-974-3 |
| MF: | C15H13N3O4S |
| Other Names: | Piroxicam |
| CAS No.: | 36322-90-4 |
| Sample: | Free |
| Market: | Worldwide |
Quick Details
Specifications
Factory Direct Piroxicam 36322-90-4 High Purity For Anti-inflammatory
Product Name: Piroxicam
Synonyms: PIROXICAM;PIROXICAMUM;2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide;2h-1,2-benzothiazine-3-carboxamide,4-hydroxy-2-methyl-n-2-pyridinyl-,1,1-diox;4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid;4-hydroxy-2-methyl-n-(2-pyridyl)-2h-1,2-benzothiazine-3-carboxamide-1,1-diox;4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide;Artroxicam
CAS: 36322-90-4
MF: C15H13N3O4S
MW: 331.35
EINECS: 252-974-3
Chemical Properties Off-White to Pale Yellow Solid
Usage Non-steroidal anti-inflammatory with long half-life. Cyclooxygenase inhibitor. Clinically useful NSAID
COA
Medical Uses
It used in the treatment of rheumatoid and osteoarthritis, primary dysmenorrhoea, postoperative pain; and act as ananalgesic, especially where there is an inflammatory component. The European Medicines Agency issued a review of its use in 2007 and recommended that its use be limited to the treatment of chronic inflammatory conditions, as it only in these circumstances that its risk-benefit ratio proves to be favourable.
Product Name: Piroxicam
Synonyms: PIROXICAM;PIROXICAMUM;2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide;2h-1,2-benzothiazine-3-carboxamide,4-hydroxy-2-methyl-n-2-pyridinyl-,1,1-diox;4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid;4-hydroxy-2-methyl-n-(2-pyridyl)-2h-1,2-benzothiazine-3-carboxamide-1,1-diox;4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide;Artroxicam
CAS: 36322-90-4
MF: C15H13N3O4S
MW: 331.35
EINECS: 252-974-3
Chemical Properties Off-White to Pale Yellow Solid
Usage Non-steroidal anti-inflammatory with long half-life. Cyclooxygenase inhibitor. Clinically useful NSAID
COA
|
Items of analysis |
Specification |
Results |
|
Characteristics |
A white or slightly yellow,crystalline powder |
slightly yellow,crystalline powder |
|
Water |
≤0.5% |
0.05% |
|
Residue on ingition |
≤0.3% |
0.08% |
|
Heavy metals |
≤0.005% |
＜0.005% |
|
Organic volatile impurities |
Conforms to U.S.P36 |
Meet the requirements |
|
Solubility |
vear slightly soluble in water,in dilute acids and in most organics solvents slightly soluble in alcohol and aqueous alkaline solutions |
Meet the requirements |
|
residualresolver |
alcohol |
Meet the requirements |
|
Assay |
97-103% |
99.1% |
|
Conclusion |
Qualified |
|
Medical Uses
It used in the treatment of rheumatoid and osteoarthritis, primary dysmenorrhoea, postoperative pain; and act as ananalgesic, especially where there is an inflammatory component. The European Medicines Agency issued a review of its use in 2007 and recommended that its use be limited to the treatment of chronic inflammatory conditions, as it only in these circumstances that its risk-benefit ratio proves to be favourable.
